Literature DB >> 26225642

Epidemiology of Prostate Cancer.

Muhammad Naeem Bashir1.   

Abstract

Prostate cancer is the most common malignancy among males worldwide, and is the second leading cause of cancer death among men in United States. According to GLOBOCAN (2012), an estimated 1.1 million new cases and 307,000 deaths were reported in 2012. The reasons for the increase of this disease are not known, but increasing life expectancy and modified diagnostic techniques have been suggested as causes. The established risk factors for this disease are advancing age, race, positive family history of prostate cancer and western diet (use of fat items). Several other risk factors, such as obesity, physical activity, sexual activity, smoking and occupation have been also associated with prostate cancer risk, but their roles in prostate cancer etiology remain uncertain. This mini-review aims to provide risk factors, disease knowledge, prevalence and awareness about prostate cancer.

Entities:  

Mesh:

Year:  2015        PMID: 26225642     DOI: 10.7314/apjcp.2015.16.13.5137

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  48 in total

1.  Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer.

Authors:  Apiwat Pugongchai; Andrey Bychkov; Pichet Sampatanukul
Journal:  Int J Exp Pathol       Date:  2018-01-08       Impact factor: 1.925

2.  The level of knowledge and awareness about prostate cancer in the Turkish male and the relevant effective factors.

Authors:  Sadi Turkan; Faruk Doğan; Ozan Ekmekçioğlu; Aslıhan Çolak; Mehmet Kalkan; Çoşkun Şahin
Journal:  Turk J Urol       Date:  2016-09

3.  Quality of sleep in patients receiving androgen deprivation therapy for prostate cancer.

Authors:  Asli Koskderelioglu; Muhtesem Gedizlioglu; Yasin Ceylan; Bulent Gunlusoy; Nilden Kahyaoglu
Journal:  Neurol Sci       Date:  2017-05-08       Impact factor: 3.307

4.  False-positive diagnosis of disease progression by magnetic resonance imaging for response assessment in prostate cancer with bone metastases: A case report and review of the pitfalls of images in the literature.

Authors:  Yi-Shan Yu; Wan-Hu Li; Ming-Huan Li; Xue Meng; L I Kong; Jin-Ming Yu
Journal:  Oncol Lett       Date:  2015-09-25       Impact factor: 2.967

5.  Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer.

Authors:  Leif-Erik D Schumacher; Alan Dal Pra; Sarah E Hoffe; Eric A Mellon
Journal:  Br J Radiol       Date:  2020-08-12       Impact factor: 3.039

6.  Curcumin for the Treatment of Prostate Diseases: A Systematic Review of Controlled Clinical Trials.

Authors:  Mohammad Bagherniya; Gholamreza Askari; Babak Alikiaii; Saeed Abbasi; Davood Soleimani; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Prostate cancer susceptibility and growth linked to Y chromosome genes.

Authors:  Riddhi Patel; Ahmad O Khalifa; Ilaha Isali; Sanjeev Shukla
Journal:  Front Biosci (Elite Ed)       Date:  2018-03-01

8.  Prostate-specific antigen screening of men with lower urinary tract symptoms (opportunistic screening) and of asymptomatic men undergoing executive health check: an audit from two institutions.

Authors:  Anil Mandhani; Varun Mittal; Ved Bhaskar; Aneesh Srivastava
Journal:  Indian J Urol       Date:  2021-04-01

9.  Prostate cancer knowledge gaps among community stakeholders in rural Nigeria: implications for seeking screening.

Authors:  Isaac Akinkunmi Adedeji; Saheed Akinmayowa Lawal; Sola Aluko-Arowolo
Journal:  Cancer Causes Control       Date:  2021-05-15       Impact factor: 2.532

10.  Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.

Authors:  Kewei Wang; Guosheng Wu; Jinping Li; Wentao Song
Journal:  BMC Cancer       Date:  2016-08-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.